TAMARA ELKINS: Open Payments
NPI 1922076702 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 110 payments from 19 companies in 2025. Trend: 2023 $2,363 · 2024 $2,953 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $701 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $389 |
| Janssen Biotech, Inc. | 11 | $342 |
| Phathom Pharmaceuticals, Inc. | 7 | $204 |
| Aimmune Therapeutics, Inc. | 8 | $153 |
| Madrigal Pharmaceuticals | 5 | $133 |
| Ardelyx, Inc. | 5 | $96 |
| Gilead Sciences, Inc. | 4 | $92 |
| VIVUS LLC | 5 | $90 |
| Lilly USA, LLC | 3 | $71 |
Products named: ENTYVIO, TREMFYA, RINVOQ, Linzess, VOQUEZNA, ZENPEP, REZDIFFRA, SKYRIZI.
Industry payments across IN — which companies pay providers there.
